Sughrue Mion, PLLC
Pharmaceutical composition containing FGF21 mutant fusion protein and method for treating hepatitis, hepatic fibrosis, and hepatic cirrhosis
A fusion protein containing a biologically active protein and an FGF21 mutant protein, a pharmaceutical composition containing the fusion protein, and their uses are disclosed. The fusion protein and the pharmaceutical composition are effective in treating a liver disease including hepatitis, hepatic fibrosis, and hepatic cirrhosis. The fusion protein has effects of inhibiting proliferation of inflammatory cells and fibroblasts, and thus can be effectively used for treating hepatitis, hepatic fibrosis, and hepatic cirrhosis.
YUHAN CORPORATION
C A A A A A A A A C A A A
C07K A61K A61K A61K A61K A61P A61K A61K A61K C07K A61K A61K A61P
inventional inventional inventional inventional inventional inventional inventional inventional inventional additional inventional inventional inventional
Jong Gyun Se Woong Taewang Moo Young Hyun Ho Dohoon Jun Hwan Han Na
Kim Oh Kim Song Choi Kim Kim Hong